Dermatologist · Johns Hopkins · United States (US) · Immunology
Data minimisation
Cadence target for Tier 1: 4 per year (assumption)
1 of 2 expected engagements
No insights captured from engagements with this stakeholder.
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 20 Apr 2026 | Medical education | In person | Rachel Adeyemi | Aurelin | Phase IIb efficacyJAK1/TYK2 selectivity+1 | 0 | MI request | Reviewed | ENG-0233 |
20 Apr 2026
Phase IIb efficacy, JAK1/TYK2 selectivity, Adolescent population
Johns Hopkins
Radiation oncologist
Thoracic medical oncologist
Primary care physician
General neurologist
Allergist